178
Views
2
CrossRef citations to date
0
Altmetric
Research Articles

Structural insights into the inhibitor binding and new inhibitor design to Polo-like kinase-1 Polo-box domain using computational studies

&
Pages 3410-3421 | Received 02 Jun 2018, Accepted 13 Aug 2018, Published online: 01 Nov 2018

References

  • Archambault, V., & Normandin, K. (2017). Several inhibitors of the Plk1 Polo-box domain turn out to be non-specific protein alkylators. Cell Cycle (Georgetown, TX), 16, 1220–1224.
  • Baker, N. A., Sept, D., Joseph, S., Holst, M. J., & McCammon, J. A. (2001). Electrostatics of nanosystems: Application to microtubules and the ribosome. Proceedings of the National Academy of Sciences, 98, 10037–10041.
  • Berendsen, H. J., Postma, J. P., Gunsteren, W. F., & Hermans, J. (1981). Interaction models for water in relation to protein hydration. In B. Pullman (Ed), Intermolecular forces (pp. 331–342). Springer: The Netherlands.
  • Berman, H. M., Battistuz, T., Bhat, T. N., Bluhm, W. F., Bourne, P. E., Burkhardt, K., … Fagan, P. (2002). The protein data bank. Acta Crystallographica. Section D, Biological Crystallography, 58, 899–907.
  • Brooks, B. R., Bruccoleri, R. E., Olafson, B. D., States, D. J., Swaminathan, S. A., & Karplus, M. (1983). CHARMM: A program for macromolecular energy, minimization, and dynamics calculations. Journal of Computational Chemistry, 4, 187–217.
  • Burkard, M. E., Santamaria, A., & Jallepalli, P. V. (2012). Enabling and disabling polo-like kinase 1 inhibition through chemical genetics. ACS Chemical Biology, 7, 978–981.
  • Bussi, G., Donadio, D., & Parrinello, M. (2007). Canonical sampling through velocity rescaling. Journal of Chemical Physics, 126, 014101.
  • Cheng, K. Y., Lowe, E. D., Sinclair, J., Nigg, E. A., & Johnson, L. N. (2003). The crystal structure of the human polo-like kinase-1 Polo box domain and its phospho-peptide complex. EMBO Journal, 22, 5757–5768.
  • Cizmecioglu, O., Warnke, S., Arnold, M., Duensing, S., & Hoffmann, I. (2008). Plk2 regulated centriole duplication is dependent on its localization to the centrioles and a functional polo-box domain. Cell Cycle (Georgetown, TX.), 7, 3548–3555.
  • Cizmecioglu, O., Krause, A., Bahtz, R., Ehret, L., Malek, N., & Hoffmann, I. (2012). Plk2 regulates centriole duplication through phosphorylation-mediated degradation of Fbxw7 (human Cdc4). Journal of Cell Science, 125, 981–992.
  • Clay, F. J., McEwen, S. J., Bertoncello, I., Wilks, A. F., & Dunn, A. R. (1993). Identification and cloning of a protein kinase-encoding mouse gene, Plk, related to the polo gene of Drosophila. Proceedings of the National Academy of Sciences, 90, 4882–4886.
  • Darden, T., York, D., & Pedersen, L. (1993). Particle mesh Ewald: An N⋅log (N) method for Ewald sums in large systems. Journal of Chemical Physics, 98, 10089–10092.
  • da Silva, A. W. S., & Vranken, W. F. (2012). ACPYPE – AnteChamber PYthon Parser interfacE. BMC Research Notes, 5, 367.
  • de Cárcer, G., Manning, G., & Malumbres, M. (2011). From Plk1 to Plk5: Functional evolution of polo-like kinases. Cell Cycle (Georgetown, TX), 10, 2255–2262.
  • de Cárcer, G., Escobar, B., Higuero, A. M., García, L., Ansón, A., Pérez, G., … Malumbres, M. (2011). Plk5, a Polo box domain-only protein with specific roles in neuron differentiation and glioblastoma suppression. Molecular and Cellular Biology, 31, 1225–1239.
  • Elia, A. E., Rellos, P., Haire, L. F., Chao, J. W., Ivins, F. J., Hoepker, K., … Yaffe, M. B. (2003). The molecular basis for phosphodependent substrate targeting and regulation of Plks by the Polo-box domain. Cell, 115, 83–95.
  • Essmann, U., Perera, L., Berkowitz, M. L., Darden, T., Lee, H., & Pedersen, L. G. (1995). A smooth particle mesh Ewald method. Journal of Chemical Physics, 103, 8577–8593.
  • Fu, J., Jiang, Q., & Zhang, C. (2010). Collaboration of mitotic kinases in cell cycle control. Nature Education, 3, 82.
  • Golsteyn, R. M., Schultz, S. J., Bartek, J., Ziemiecki, A., Ried, T., & Nigg, E. A. (1994). Cell cycle analysis and chromosomal localization of human Plk1, a putative homologue of the mitotic kinases Drosophila polo and Saccharomyces cerevisiae Cdc5. Journal of Cell Science, 107, 1509–1517.
  • Halgren, T. A. (1996). Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94. Journal of Computational Chemistry, 17, 490–519.
  • Hamanaka, R., Smith, M. R., O'Connor, P. M., Maloid, S., Mihalic, K., Spivak, J. L., … Ferris, D. K. (1995). Polo-like kinase is a cell cycle-regulated kinase activated during mitosis. Journal of Biological Chemistry, 270, 21086–21091.
  • Hess, B., Kutzner, C., Van Der Spoel, D., & Lindahl, E. (2008). GROMACS 4: Algorithms for highly efficient, load-balanced, and scalable molecular simulation. Journal of Chemical Theory and Computation, 4, 435–447.
  • Hess, B., Bekker, H., Berendsen, H. J., & Fraaije, J. G. (1997). LINCS: A linear constraint solver for molecular simulations. Journal of Computational Chemistry, 18, 1463–1472.
  • Homeyer, N., & Gohlke, H. (2012). Free energy calculations by the molecular mechanics Poisson–Boltzmann surface area method. Molecular Informatics, 31, 114–122.
  • Hornak, V., Abel, R., Okur, A., Strockbine, B., Roitberg, A., & Simmerling, C. (2006). Comparison of multiple Amber force fields and development of improved protein backbone parameters. Proteins: Structure, Function, and Bioinformatics, 65, 712–725.
  • Iida, M., Matsuda, M., & Komatani, H. (2008). Plk3 phosphorylates topoisomerase IIalpha at Thr(1342), a site that is not recognized by Plk1. Biochemical Journal, 411, 27–32.
  • Irwin, J. J., Sterling, T., Mysinger, M. M., Bolstad, E. S., & Coleman, R. G. (2012). ZINC: A free tool to discover chemistry for biology. Journal of Chemical Information and Modeling, 52, 1757–1768.
  • Lee, K. S., Grenfell, T. Z., Yarm, F. R., & Erikson, R. L. (1998). Mutation of the Polo-box disrupts localization and mitotic functions of the mammalian Polo kinase Plk. Proceedings of the National Academy of Sciences of the United States of America, 95, 9301–9306.
  • Kortagere, S., Ekins, S., & Welsh, W. J. (2008). Halogenated ligands and their interactions with amino acids: Implications for structure–activity and structure–toxicity relationships. Journal of Molecular Graphics and Modelling, 27, 170–177.
  • Kumari, R., Kumar, R., Open Source Drug Discovery Consortium, & Lynn, A. (2014). g_mmpbsa-a GROMACS tool for high-throughput MM-PBSA calculations. Journal of Chemical Information and Modeling, 54, 1951–1962.
  • Mendez, L., Henriquez, G., Sirimulla, S., & Narayan, M. (2017). Looking back, looking forward at halogen bonding in drug discovery. Molecules, 22, 1397.
  • Normandin, K., Lavallée, J. F., Futter, M., Beautrait, A., Duchaine, J., Guiral, S., … Archambault, V. (2016). Identification of Polo-like kinase 1 interaction inhibitors using a novel cell-based assay. Scientific Reports, 5, 37581.
  • Park, J. E., Soung, N. K., Johmura, Y., Kang, Y. H., Liao, C., Lee, K. H., … Lee, K. S. (2010). Polo-box domain: A versatile mediator of polo-like kinase function. Cellular and Molecular Life Sciences: CMLS, 67, 1957–1970.
  • Parrinello, M., & Rahman, A. (1981). Polymorphic transitions in single crystals: A new molecular dynamics method. Journal of Applied Physics, 52, 7182–7190.
  • Pettersen, E. F., Goddard, T. D., Huang, C. C., Couch, G. S., Greenblatt, D. M., Meng, E. C., & Ferrin, T. E. (2004). UCSF Chimera – A visualization system for exploratory research and analysis. Journal of Computational Chemistry, 25, 1605–1612.
  • Qin, T., Chen, F., Zhuo, X., Guo, X., Yun, T., Liu, Y., … Lai, L. (2016). Discovery of novel polo-like kinase 1 Polo-box domain inhibitors to induce mitotic arrest in tumor cells. Journal of Medicinal Chemistry, 59, 7089–7096.
  • Reindl, W., Yuan, J., Krämer, A., Strebhardt, K., & Berg, T. (2008). Inhibition of Polo-like kinase 1 by blocking polo-box domain-dependent protein–protein interactions. Chemistry & Biology, 15, 459–466.
  • Rudolph, D., Steegmaier, M., Hoffmann, M., Grauert, M., Baum, A., Quant, J., … Adolf, G. R. (2009). BI 6727, a Polo-like kinase inhibitor with improved pharmacokinetic profile and broad antitumor activity. Clinical Cancer Research, 15, 3094–3102.
  • Šali, A., & Blundell, T. L. (1993). Comparative protein modelling by satisfaction of spatial restraints. Journal of Molecular Biology, 234, 779–815.
  • Saxena, S., Abdullah, M., Sriram, M., & Guruprasad, L. (2017). Discovery of novel inhibitors of Mycobacterium tuberculosis MurG: Homology modelling, structure based pharmacophore, molecular docking, and molecular dynamics simulations. Journal of Biomolecular Structure and Dynamics. doi: 10.1080/07391102.2017.1384398
  • Scharow, A., Raab, M., Saxena, K., Sreeramulu, S., Kudlinzki, D., Gande, S., … Schwalbe, H. (2015). Optimized Plk1 PBD inhibitors based on poloxin induce mitotic arrest and apoptosis in tumor cells. ACS Chemical Biology, 10, 2570–2579.
  • Shiri, F., Pirhadi, S., & Ghasemi, J. B. (2018). Dynamic structure based pharmacophore modeling of the Acetylcholinesterase reveals several potential inhibitors. Journal of Biomolecular Structure and Dynamics, 1. doi: 10.1080/07391102.2018.1468281
  • Sirimulla, S., Bailey, J. B., Vegesna, R., & Narayan, M. (2013). Halogen interactions in protein–ligand complexes: Implications of halogen bonding for rational drug design. Journal of Chemical Information and Modeling, 53, 2781–2791.
  • Sunkel, C. E., & Glover, D. M. (1988). Polo, a mitotic mutant of Drosophila displaying abnormal spindle poles. Journal of Cell Science, 89, 25–38.
  • Sunseri, J., & Koes, D. R. (2016). Pharmit: Interactive exploration of chemical space. Nucleic Acids Research, 44, W442–W448.
  • Van Der Spoel, D., Lindahl, E., Hess, B., Groenhof, G., Mark, A. E., & Berendsen, H. J. (2005). GROMACS: Fast, flexible, and free. Journal of Computational Chemistry, 26, 1701–1718.
  • Wang, J., Wang, W., Kollman, P. A., & Case, D. A. (2006). Automatic atom type and bond type perception in molecular mechanical calculations. Journal of Molecular Graphics and Modelling, 25, 247–260.
  • Wang, J. D., & Levin, P. A. (2009). Metabolism, cell growth and the bacterial cell cycle. Nature Reviews Microbiology, 7, 822.
  • Wu, G., Robertson, D. H., Brooks, C. L., & Vieth, M. (2003). Detailed analysis of grid‐based molecular docking: A case study of CDOCKER – A CHARMm‐based MD docking algorithm. Journal of Computational Chemistry, 24, 1549–1562.
  • Yun, T., Qin, T., Liu, Y., & Lai, L. (2016). Identification of acylthiourea derivatives as potent Plk1 PBD inhibitors. European Journal of Medicinal Chemistry, 124, 229–236.
  • Yun, S. M., Moulaei, T., Lim, D., Bang, J. K., Park, J. E., Shenoy, S. R., … Lee, S. (2009). Structural and functional analyses of minimal phosphopeptides targeting the polo-box domain of polo-like kinase 1. Nature Structural & Molecular Biology, 16, 876.
  • Zoete, V., Daina, A., Bovigny, C., & Michielin, O. (2016). SwissSimilarity: A web tool for low to ultra high throughput ligand-based virtual screening. Journal of Chemical Information and Modeling, 56, 1399–1404.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.